ID   BB90-MEL
AC   CVCL_VU92
SY   BB 90 MEL; DEZE
DR   IPD-IMGT/HLA; 12039
DR   Wikidata; Q93423445
RX   PubMed=10885573;
RX   PubMed=11751535;
RX   PubMed=14707109;
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   HLA typing: A*02:01,26:01; B*15:01,44:02; C*03:04,05:03 (IPD-IMGT/HLA=12039).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 5
//
RX   PubMed=10885573; DOI=10.1034/j.1399-0039.2000.550515.x;
RA   Huang L.-Q., Boon T., Van Pel A.;
RT   "Identification of a novel HLA-Cw*05 allele, Cw*0503.";
RL   Tissue Antigens 55:473-474(2000).
//
RX   PubMed=11751535; DOI=10.1093/clinchem/48.1.25;
RA   Zammatteo N., Lockman L., Brasseur F., De Plaen E., Lurquin C.,
RA   Lobert P.-E., Hamels S., Boon T., Remacle J.;
RT   "DNA microarray to monitor the expression of MAGE-A genes.";
RL   Clin. Chem. 48:25-34(2002).
//
RX   PubMed=14707109; DOI=10.4049/jimmunol.172.2.1304;
RA   Schultz E.S., Schuler-Thurner B., Stroobant V., Jenne L., Berger T.G.,
RA   Thielemans K., van der Bruggen P., Schuler G.;
RT   "Functional analysis of tumor-specific Th cell responses detected in
RT   melanoma patients after dendritic cell-based immunotherapy.";
RL   J. Immunol. 172:1304-1310(2004).
//